107 related articles for article (PubMed ID: 2521552)
1. The role of pirenzepine-sensitive (M1) muscarinic receptors in vagally mediated bronchoconstriction in humans.
Lammers JW; Minette P; McCusker M; Barnes PJ
Am Rev Respir Dis; 1989 Feb; 139(2):446-9. PubMed ID: 2521552
[TBL] [Abstract][Full Text] [Related]
2. A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction.
Bloom JW; Yamamura HI; Baumgartener C; Halonen M
Eur J Pharmacol; 1987 Jan; 133(1):21-7. PubMed ID: 3556389
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma.
Crimi N; Palermo F; Oliveri R; Polosa R; Settinieri I; Mistretta A
Eur Respir J; 1992 May; 5(5):560-5. PubMed ID: 1535321
[TBL] [Abstract][Full Text] [Related]
4. Functional evidence of excitatory M1 receptors in the rabbit airway.
Matsumoto S
J Pharmacol Exp Ther; 1997 Apr; 281(1):531-9. PubMed ID: 9103541
[TBL] [Abstract][Full Text] [Related]
5. Conditional involvement of muscarinic M1 receptors in vagally mediated contraction of guinea-pig bronchi.
ten Berge RE; Roffel AF; Zaagsma J
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):173-8. PubMed ID: 7477440
[TBL] [Abstract][Full Text] [Related]
6. Effect of pirenzepine and gallamine on cardiac and pulmonary muscarinic receptors in the rabbit.
Maclagan J; Faulkner D
Br J Pharmacol; 1989 Jun; 97(2):506-12. PubMed ID: 2758229
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the bronchodilator efficacy of nebulized pirenzepine and ipratropium bromide in patients with airway obstructive lung disease.
Ceyhan B; Celikel T; Simsir S; Kandemir B
Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):510-3. PubMed ID: 8262690
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition.
Mann JS; Cushley MJ; Holgate ST
Am Rev Respir Dis; 1985 Jul; 132(1):1-6. PubMed ID: 2990269
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic M-1 receptors mediate the bronchial hyperresponsiveness during methacholine inhalation.
Cazzola M; Matera MG; D'Amato G; De Novellis V; Marmo E
Int J Clin Pharmacol Res; 1989; 9(1):71-6. PubMed ID: 2707928
[TBL] [Abstract][Full Text] [Related]
10. Identification of M1 muscarinic receptors in pulmonary sympathetic nerves in the guinea-pig by use of pirenzepine.
Maclagan J; Fryer AD; Faulkner D
Br J Pharmacol; 1989 Jun; 97(2):499-505. PubMed ID: 2758228
[TBL] [Abstract][Full Text] [Related]
11. Ipratropium bromide potentiates bronchoconstriction induced by vagal nerve stimulation in the guinea-pig.
Fryer AD; Maclagan J
Eur J Pharmacol; 1987 Jul; 139(2):187-91. PubMed ID: 2958300
[TBL] [Abstract][Full Text] [Related]
12. A muscarinic receptor subtype modulates vagally stimulated bronchial contraction.
Bloom JW; Baumgartener-Folkerts C; Palmer JD; Yamamura HI; Halonen M
J Appl Physiol (1985); 1988 Nov; 65(5):2144-50. PubMed ID: 3209557
[TBL] [Abstract][Full Text] [Related]
13. Effect of a M1-selective muscarinic receptor antagonist (pirenzepine) on basal bronchomotor tone in young women.
Fujimura M; Kamio Y; Matsuda T
Respiration; 1992; 59(2):102-6. PubMed ID: 1620977
[TBL] [Abstract][Full Text] [Related]
14. Ipratropium bromide: bronchodilator action and effect on methacholine-induced bronchoconstriction.
Larsson K
J Asthma; 1987; 24(1):29-35. PubMed ID: 2975285
[TBL] [Abstract][Full Text] [Related]
15. Protection by ipratropium bromide and metaproterenol against methacholine and histamine bronchoconstriction.
Nair N; Townley RG; Watt G; Schlanger S; Bewtra AK; Stekoll LH
Clin Allergy; 1984 Jan; 14(1):11-9. PubMed ID: 6230176
[TBL] [Abstract][Full Text] [Related]
16. Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease.
On LS; Boonyongsunchai P; Webb S; Davies L; Calverley PM; Costello RW
Am J Respir Crit Care Med; 2001 May; 163(6):1320-5. PubMed ID: 11371395
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic blockade of methacholine induced airway and parenchymal lung responses in anaesthetised rats.
Tulić MK; Wale JL; Peták F; Sly PD
Thorax; 1999 Jun; 54(6):531-7. PubMed ID: 10335008
[TBL] [Abstract][Full Text] [Related]
18. Rebound hyperresponsiveness to muscarinic stimulation after chronic therapy with an inhaled muscarinic antagonist.
Newcomb R; Tashkin DP; Hui KK; Conolly ME; Lee E; Dauphinee B
Am Rev Respir Dis; 1985 Jul; 132(1):12-5. PubMed ID: 3160272
[TBL] [Abstract][Full Text] [Related]
19. [The effect of muscarinic receptor blockers on non-specific bronchial reactivity in patients with bronchial asthma].
Siergiejko Z
Pneumonol Alergol Pol; 1992; 60(11-12):32-6. PubMed ID: 1303776
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic blockade of beta-blocker-induced bronchoconstriction.
Ind PW; Dixon CM; Fuller RW; Barnes PJ
Am Rev Respir Dis; 1989 Jun; 139(6):1390-4. PubMed ID: 2658700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
